With the demand for vaccine development, Creative Diagnostics have developed two ELISA Kits for qualitative detection of SARS-CoV-2 neutralizing antibody in serum and plasma.
Creative Diagnostics has launched a full series of ELISA kits for coronavirus antibody detection, including SARS-CoV-2, SARS-CoV, HCoV 229E, HCoV NL63, HCoV OC43 and HCoV HKU1.
Creative Diagnostics provides a list of high-affinity neutralization NRP1 antibodies for your SARS-CoV-2 Intervention Research.
Multiple SARS-CoV-2 variants (B.1.1.7; 501Y.V2) are circulating globally. Creative Diagnostics has produced a collection of recombinant antigens and lentiviral pseudovirus for these variants.
Creative Diagnostics now can provide SARS-CoV-2 Neutralizing Antibodies. These antibodies can be used as reference antibodies in neutralization assays and may also be used in animal research.
Creative Diagnostics now can provide recombinant SARS-CoV-2 accessory proteins and related antibodies.
Creative Diagnostics has developed a panel of serotype-specific S. pneumoniae CPS antibodies for streptococcus pneumoniae vaccines research.
Creative Diagnostics now can provide PLA2R and THSD7A high expressed stable cell lines, which can be used in PLA2R/TSHD7A autoantibody IFA development. Anti-PLA2R/THSD7A IFA Kit is also available for research use.
In response to the COVID-19 pandemic, Creative Diagnostics is now offering the SARS-CoV-2 nucleoprotein antibody pair for rapid COVID-19 antigen assays to equip healthcare workers for rapid COVID-19 antigen detection. We also offer SARS-CoV-2 antigen extraction buffer tubes that can be used as packing supplies for SARS-CoV-2 antigen extraction.
Lentiviral SARS-CoV-2 Pseudovirus
Creative Diagnostics now can provide Native Human Prealbumin and matched antibody pairs for assay development. These reagents can be used for prealbumin detection in both ELISA and Immunoturbidimetric.
Creative Diagnostics now can provide recombinant SARS-CoV-2 RBD mutants expressed in HEK293 cells. Some of these antigens have higher affinity to human ACE2.
Creative Diagnostics now can provide matched antigen pair of SARS-CoV-2 spike/RBD. These antigens have been validated for SARS-CoV-2 total antibodies detection in double-antigen sandwich immunoassay.
This cell line is constructed by transduction of human angiotensin I converting enzyme 2 (ACE2) into HEK293T cells, followed by stable cell selection. HEK293T is derived from HEK293 and is commonly used in scientific research.
Creative Diagnostics now offers immunoassay kits for direct detection of the new coronavirus and antibodies against SARS-CoV-2
SARS coronavirus, also known as SARS-CoV, emerged in the human population in Guangdong province of southeastern, China in 2002, Within months, the outbreak had spread to 29 countries and regions causing over 8000 human cases and almost 800 deaths in the 2002-2003 outbreak.
The Middle East respiratory syndrome-related coronavirus, also known as MERS-CoV, which was first reported in Saudi Arabia in 2012. MERS-CoV is a zoonotic virus, which means it is a virus that is transmitted between animals and people.
Coronaviruses are named for the crown-like spikes on their surface. Human coronaviruses (HCoVs) are enveloped, single-stranded, positive-sense RNA viruses that belong to the coronaviridae family.
Creative Diagnostics now can provide recombinant 2019-nCoV antigens. These antigens can be used for scientific research, detection of novel coronavirus and preparation of neutralizing antibodies.
Creative Diagnostics is proud to offer Africa swine fever virus antigens and antibodies. These antigens and antibodies have been validated to work in various types of immunoassays and can be supplied as high quality tools for ASFV detection.